This month's dividend screen highlights a new name amid volatility, focusing on safety, growth, and consistency. Check out ...

Engie will no longer be exposed to nuclear waste management costs. Read why ENGIY stock offers a compelling investment case.

UnitedHealth Group faces real PBM reform risks, but legal paths, financials, and market pricing suggest opportunity in ...

VWOB is an emerging market debt index ETF. Click here to read more about VWOB ETF and why it is rated as a Buy.

PFO offers little compensation for its higher leverage and risk profile. Read why I see no compelling reason to prefer PFO ...

Booz Allen offers AI and cybersecurity solutions with strong financials, growing contracts, and strategic partnerships. Read ...

Terna is accelerating its CapEx, notably on €23B 2024–2028 industrial plan. Read why I believe a more appropriate rating is ...

Goldman Sachs has outperformed the S&P 500 and the financial sector. Click here to read why I reiterate my Buy rating for GS ...

Enterprise Products Partners boasts low leverage, a hefty yield of 6.88%, and ongoing growth projects. Read why EPD stock is ...

Alibaba leads in AI adoption and merchant productivity enhancements. Click here to read why BABA stock is upgraded to Buy.

I now believe that HighPeak can deliver slightly above the high-end of its full-year guidance for production. Read why HPK ...

Gladstone Investment's baby bonds, particularly GAINZ and GAINI, offer compelling yields to maturity near 8%. Read more about ...